3-iodobenzylguanidine has been researched along with Adenocarcinoma, Follicular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albertson, DA; Cooper, MR; Cowan, RJ; Thomas, CC | 1 |
| Lin, WY; Shen, YY; Wang, SJ | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Adenocarcinoma, Follicular
| Article | Year |
|---|---|
Detection of medullary carcinoma of the thyroid with I-131 MIBG.
Topics: 3-Iodobenzylguanidine; Adenocarcinoma, Follicular; Antineoplastic Agents; Carcinoma, Medullary; Humans; Iodine Radioisotopes; Iodobenzenes; Liver Neoplasms; Male; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Sulfur Colloid; Thyroid Neoplasms | 1994 |
Short-term hazards of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.
Topics: 3-Iodobenzylguanidine; Adenocarcinoma, Follicular; Adult; Aged; Aged, 80 and over; Carcinoma, Papillary; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Nausea; Pain; Prospective Studies; Radionuclide Imaging; Radiotherapy, Adjuvant; Thyroid Neoplasms; Xerostomia | 1996 |